Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Effect of renal impairment on the pharmacokinetics, pharmacodynamics, and safety of apixabanother · 2015 · 174 citations
2. 2Apixaban versus Warfarin in Patients with Atrial FibrillationRCT · 2011 · 9,005 citations
3. 3Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysiscohort · 2015 · 289 citations
4. 4Oral Apixaban for the Treatment of Acute Venous ThromboembolismRCT · 2013 · 2,338 citations
5. 5Evaluation of the appropriateness of dosing, indication and safety of rivaroxaban in a community hospitalcohort · 2015 · 34 citations